These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17295647)

  • 1. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
    Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
    Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances.
    Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K
    Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: morphologic, immunohistochemical, and FISH analyses.
    Pan Y; Meng B; Sun B; Guan B; Liang Y; Wang H; Hao X; Fu K
    Diagn Mol Pathol; 2012 Dec; 21(4):234-40. PubMed ID: 22968395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2.
    Gollub W; Stassek B; Huckhagel T; Bernd HW; Krokowski M; Merz H; Feller AC; Thorns C
    Anticancer Res; 2009 Nov; 29(11):4649-55. PubMed ID: 20032416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA signatures in subtypes of follicular lymphoma.
    Gebauer N; Gollub W; Stassek B; Bernard V; Rades D; Feller AC; Thorns C
    Anticancer Res; 2014 May; 34(5):2105-11. PubMed ID: 24778012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular lymphoma of the spleen: multiparameter analysis of 16 cases.
    Howard MT; Dufresne S; Swerdlow SH; Cook JR
    Am J Clin Pathol; 2009 May; 131(5):656-62. PubMed ID: 19369624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic significance of
    Kim M; Hwang HS; Son EM; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
    Leuk Lymphoma; 2020 Dec; 61(14):3342-3350. PubMed ID: 32921221
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
    Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
    Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
    Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
    Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
    Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
    Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular lymphoma grade 3B.
    Salaverria I; Siebert R
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):111-9. PubMed ID: 21658612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
    Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
    Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
    Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation.
    Karube K; Ying G; Tagawa H; Niino D; Aoki R; Kimura Y; Hashikawa K; Suefuji N; Sugita Y; Nomura Y; Shimizu K; Yoshida S; Seto M; Ohshima K
    Mod Pathol; 2008 Aug; 21(8):973-8. PubMed ID: 18500267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.
    McCluggage WG; Catherwood M; Alexander HD; McBride HA; Smith ME; Morris TC
    Histopathology; 2002 Nov; 41(5):414-20. PubMed ID: 12405909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
    Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
    Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy.
    Magnoli F; Marchiori D; Facchi S; Martin V; Campiotti L; Merli M; Sessa F; Tibiletti MG; Uccella S
    Cancer Genet; 2023 Jun; 274-275():1-9. PubMed ID: 36917896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.
    Zha H; Raffeld M; Charboneau L; Pittaluga S; Kwak LW; Petricoin E; Liotta LA; Jaffe ES
    Lab Invest; 2004 Feb; 84(2):235-44. PubMed ID: 14767488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.